Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 Growth stocks to Buy with MASSIVE Upside potential.

1 extracted signal · 0 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
17 Mar 2026, 22:30 UTC
Recorded by Tahlil Plus
18 May 2026, 20:24 UTC
Video preview for Friends! In this video, I'm going to discuss 2 Growth stocks to Buy with MASSIVE Upside potential.
Source overview

AI-generated source summary

The market analysis covers two stocks: GRAB, a delivery and financial services company in Southeast Asia, and RDDT, a social media platform. GRAB's stock is down year-to-date, influenced by higher oil and natural gas prices, but its diverse business model and growth in Vietnam are noted. The company's financial services segment and its acquisition of Stash are also discussed. RDDT, despite a significant year-to-date decline, is highlighted for its massive user base and engagement, with a valuation that appears low. The analysis suggests both stocks have potential for growth, with GRAB's financials showing positive trends and RDDT's user engagement indicating a strong advertising business, though competition and user growth deceleration are potential risks.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
1
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.0
Tracked signals
337
Historical success
33.6%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail